CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel; Maja Ølholm Vase; Kristina Lystlund Lauridsen; Marie Beck Enemark; Michael Boe Møller; Court Pedersen; Gitte Pedersen; Stephen Hamilton-Dutoit; Niels Obel; Carsten Schade Larsen; Francesco d'Amore; Maja Ludvigsen

doi:10.1080/10428194.2021.2023741

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, Maja Ludvigsen

Afdeling for Infektionssygdomme

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia and Lymphoma
Vol/bind	63
Udgave nummer	6
Sider (fra-til)	1479-1483
Antal sider	5
ISSN	1042-8194
DOI	https://doi.org/10.1080/10428194.2021.2023741
Status	Udgivet - jun. 2022

Adgang til dokumentet

10.1080/10428194.2021.2023741

Andre filer og links

Link to publication in Scopus

Citationsformater

Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d'Amore, F., & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia and Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

Hybel, TE, Vase, MØ, Lauridsen, KL, Enemark, MB, Møller, MB, Pedersen, C, Pedersen, G, Hamilton-Dutoit, S, Obel, N, Schade Larsen, C, d'Amore, F & Ludvigsen, M 2022, 'CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus', Leukemia and Lymphoma, bind 63, nr. 6, s. 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

@article{d1806891a9c74f9bace8b9a922fa2fac,

title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",

keywords = "ADP-ribosyl Cyclase 1, HIV, HIV Infections/complications, Humans, Lymphoma/complications",

author = "Hybel, {Trine Engelbrecht} and Vase, {Maja {\O}lholm} and Lauridsen, {Kristina Lystlund} and Enemark, {Marie Beck} and M{\o}ller, {Michael Boe} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and {Schade Larsen}, Carsten and Francesco d'Amore and Maja Ludvigsen",

year = "2022",

month = jun,

doi = "10.1080/10428194.2021.2023741",

language = "English",

volume = "63",

pages = "1479--1483",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

AU - Hybel, Trine Engelbrecht

AU - Vase, Maja Ølholm

AU - Lauridsen, Kristina Lystlund

AU - Enemark, Marie Beck

AU - Møller, Michael Boe

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Hamilton-Dutoit, Stephen

AU - Obel, Niels

AU - Schade Larsen, Carsten

AU - d'Amore, Francesco

AU - Ludvigsen, Maja

PY - 2022/6

Y1 - 2022/6

KW - ADP-ribosyl Cyclase 1

KW - HIV

KW - HIV Infections/complications

KW - Humans

KW - Lymphoma/complications

UR - http://www.scopus.com/inward/record.url?scp=85122825283&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.2023741

DO - 10.1080/10428194.2021.2023741

M3 - Letter

C2 - 35019824

SN - 1042-8194

VL - 63

SP - 1479

EP - 1483

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -